Gros David-Alexandre C Insider Trading
Get the latest insider transactions of Gros David-Alexandre C. Gros David-Alexandre C is President & COO in NEUROCRINE BIOSCIENCES INC ($NBIX) and SVP, Chief Business Officer in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and Chief Executive Officer in Novus Therapeutics, Inc. ($NVUS). Discover the current value of Gros David-Alexandre C shares.
Address: 300 THIRD STREET CAMBRIDGE 02142MA
Gros David-Alexandre C is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
ALNY | ALNYLAM PHARMACEUTICALS, INC. | SVP, Chief Business Officer | 1,000 | 40,460.00 |
NBIX | NEUROCRINE BIOSCIENCES INC | President & COO | 0 | 0.00 |
ELDN | Eledon Pharmaceuticals, Inc. | Chief Executive Officer | 3,000 | 2,730.00 |
Insider Trading Transactions of Gros David-Alexandre C
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Jun 10 2021 | ELDN | Eledon Pharmaceuticals, I ... | Gros David-Alexandre C | Chief Executive Offic ... | Buy | 8.01 | 3,000 | 24,030 | 3,000 |
Sep 15 2020 | NVUS | Novus Therapeutics, Inc. | Gros David-Alexandre C | Chief Executive Offic ... | Option Exercise | 500.00 | 18,278 | 9,139,000 | 18,278 |
Feb 08 2017 | NBIX | NEUROCRINE BIOSCIENCES IN ... | Gros David-Alexandre C | President & COO | Option Exercise | 0.00 | 25,000 | 0 | 25,000 |
Feb 02 2017 | NBIX | NEUROCRINE BIOSCIENCES IN ... | Gros David-Alexandre C | President & COO | Option Exercise | 42.55 | 350,000 | 14,892,500 | 350,000 |
Dec 22 2016 | ALNY | ALNYLAM PHARMACEUTICALS, ... | Gros David-Alexandre C | SVP, Chief Business O ... | Option Exercise | 42.22 | 25,000 | 1,055,500 | 25,000 |
Feb 24 2016 | ALNY | ALNYLAM PHARMACEUTICALS, ... | Gros David-Alexandre C | SVP, Chief Business O ... | Buy | 62.74 | 100 | 6,274 | 100 |
Feb 24 2016 | ALNY | ALNYLAM PHARMACEUTICALS, ... | Gros David-Alexandre C | SVP, Chief Business O ... | Buy | 62.75 | 900 | 56,475 | 1,000 |
Dec 22 2015 | ALNY | ALNYLAM PHARMACEUTICALS, ... | Gros David-Alexandre C | SVP, Chief Business O ... | Option Exercise | 88.95 | 15,012 | 1,335,317 | 15,012 |
Jun 10 2015 | ALNY | ALNYLAM PHARMACEUTICALS, ... | Gros David-Alexandre C | SVP, Chief Business O ... | Option Exercise | 129.97 | 140,000 | 18,195,800 | 140,000 |